SCHEMBL845330

SCHEMBL845330

CCCOc1cccnc1C(=O)N1CCC[C@H]1C(=O)Nc1ccc(/C=C/c2ccc(NC(=O)[C@@H]3CCCN3C(=O)c3ncccc3OCCC)cc2)cc1

nearest known ligand 0.47

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.47
PDE5A O76074 1/20 0.46
PABPC1 P11940 1/20 0.45
LMNA P02545 2/20 0.43
KDM4E B2RXH2 1/20 0.43
MAPK1 P28482 2/20 0.43
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
HCRTR1 O43613 2/20 0.41
HCRTR2 O43614 2/20 0.41
ALDH1A1 P00352 2/20 0.41
HTT P42858 1/20 0.41
TSHR P16473 2/20 0.40
ROCK2 O75116 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
NPC1 O15118 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL871971 0.92 PDE5A (0.42) GAAPDE5APABPC1LMNAKDM4E
SCHEMBL845060 0.87 KDM4E (0.51) GAAPABPC1LMNAKDM4ECYP2C9
SCHEMBL845518 0.86 GAA (0.52) GAAPDE5APABPC1LMNAKDM4E
SCHEMBL845697 0.84 ALDH1A1 (0.45) PABPC1MAPK1CYP2C9CYP2C19ALDH1A1
SCHEMBL845433 0.83 PABPC1 (0.42) GAAPABPC1LMNAKDM4EMAPK1
SCHEMBL845442 0.83 CYP2C9 (0.43) PABPC1MAPK1CYP2C9CYP2C19ALDH1A1
SCHEMBL845301 0.80 PABPC1 (0.51) GAAPABPC1LMNAKDM4EMAPK1
SCHEMBL873781 0.80 KDM4E (0.44) GAAPABPC1LMNAKDM4ECYP2C9
SCHEMBL13272511 0.80 KDM4E (0.43) GAAPABPC1LMNAKDM4ECYP2C9
SCHEMBL13272509 0.80 TRPV1 (0.45) PABPC1LMNAKDM4EMAPK1CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed
EP-1893573-B1 INHIBITORS OF HCV REPLICATION BRISTOL MYERS SQUIBB CO (US) 2010-07-21 EP disclosed